Internal Echoes and Posterior Features
The high reflectivity of the anterior cyst wall often gives rise to reverberations (Figs. 7.6 a, b; 7.7 a, b), a band of echoes from the cyst wall that project into the interior of the cyst. These artifacts may be mistaken for solid areas of wall thickening. By moving the transducer and alternating compression and decompression, or by changing the angle of the transducer against the breast tissue or altering the patient's position somewhat, the examiner can cause the reverberations to shift their position within the cyst and confirm them as artifacts. In addition, reverberations can be reduced by lowering the gain or power settings. Because the focal zone setting represents the highest concentration of acoustic energy, shifting the focal zone to a deeper level may also diminish the reverberations. Cysts occasionally contain low-level internal echoes if the cyst fluid is inspissated, if the fluid contains hemosiderin, or if the cellularity of the fluid is increased (Fig. 7.8 a, b) . This type of cyst, a complicated cyst in BI-RADS nomenclature, may resemble a fibroadenoma, especially when a transducer of 10 MHz or higher frequency is used. If doubt exists, cyst/solid differentiation can be accomplished by ultrasound-guided aspiration ( Fig. 7.8 a, b) . Despite their internal echoes, these cysts usually show an enhanced pattern of sound transmission. The cyst contents may also cause sound attenuation, producing a posterior acoustic shadow that creates the impression of a suspicious solid mass (Figs. 7.9 a, b; 7.10 a, b). This effect is common in cysts that contain milk of calcium and inflammatory cysts. The shadowing is most conspicuous when a high-frequency transducer is used. Comment: Typical cysts can be identified with ultrasound and usually do not require aspiration or biopsy unless they are causing complaints or subjectively unpleasant nodularity. The large cysts (a) are clearly defined. The unilateral edge shadow (b) arises from a Cooper ligament that is oblique to the beam direction. Behind and to the left of the cyst is a smaller cyst (3 mm in diameter) cut off-center by the scanning plane. Because of this eccentricity, the cyst walls appears indistinct. Because of the multiple septa, the internal structure of the cyst is unclear (b). The fibrous changes in the surrounding tissue cause increased scattering and refraction, making it difficult to evaluate the septa and wall contours. Comment: Reverberations appear under compression and in the noncompression scans. Real-time scanning with dynamic compression identifies the echoes as reverberations rather than intracystic structures. As pressure is applied and released, the echoes move up and down within the cyst as the transducer moves closer to and farther from the anterior cyst wall. As compression is increased, the layer of subcutaneous fat becomes thinner and the transducer moves closer to the cyst, causing the reverberations to appear closer together. Comment: Screening mammograms in this 60-year-old woman showed two densities in the left breast. When ultrasound revealed internal echoes, the patient was hospitalized for surgery. Ultrasound-guided aspiration yielded hemosiderin-containing fluid with no evidence of proliferation. Comment: The axial orientation of the lesions is indeterminate because of acoustic shadowing (only the horizontal dimension can be measured). Similarly, compressibility cannot be assessed because the posterior wall is not defined. The lack of sound transmission through the cysts makes it impossible to evaluate the surrounding structures, and so the architecture is uninterpretable.
A
Sound absorption by the dense fluid gives rise to a suspicious ultrasound pattern, but aspiration promptly identified the lesions as cysts. If the mammograms were also suspicious, core biopsy or primary excision would have been indicated.
Fluid Levels and Oil Cysts
Fluid levels develop in cysts that contain liquids with different specific gravities (Fig. 7.11 ). Fluid levels often form when immiscible oily and watery fluid phases coexist in the same cyst. The oily phase, which is usually more echogenic, floats on top of the watery phase and creates a fluid-fluid level. This phenomenon is also seen in galactoceles, milk collections found in lactating women where the hyperechoic, high-fat cream layer is found anteriorly while the anechoic, watery component of milk occupies the deeper portion of the cystic lesion. When the patient is moved from the supine to a sitting position, the level will gradually shift in response to gravity. A layering effect also occurs when cyst fluid becomes inspissated and the more echogenic material settles to the cyst floor.
When the cysts contain only liquefied fat or oil (fat necrosis), the mass may appear anechoic or hypoechoic, and either posterior enhancement or shadowing may be associated with it. The clinical history of accidental or surgical trauma may support the diagnosis and correlating the sonographic finding with a circumscribed radiolucent mammographic mass will establish the benign etiology without need for intervention.
Clustered Microcysts
Multiple microcysts that are aggregated in a cluster may form a palpable mass with indistinct margins that is difficult to evaluate clinically. An area of increased soft tissue density, at times partially circumscribed, may be the only mammographic manifestation. The tiny individual cystic components are poorly resolved, and only an ill-defined hypoechoic mass may be seen using lowerfrequency transducers or ultrasound systems of poor quality. High-resolution scanners can usually define the individual microcysts that comprise the lesion (see Fig. 7.2) . Occasionally, these microcysts, dilated lobular acini, contain small, bright, punctate mural echoes that correlate with microcalcifications (see Fig. 7.5 a,  b) . Ultrasound is not a suitable modality for the primary detection of microcalcifications, but once microcalcifications have been identified on mammograms, ultrasound can help identify their source when they are located in microcysts. These microcystic conglomerations should be carefully interrogated sonographically to identify or exclude a solid component. If there is no solid component, clustered microcysts can be considered probably benign with two initial short interval follow-up visits (commonly at 6-month intervals) with annual follow-ups thereafter.
If a solid component is found, ultrasound should be used to guide core biopsy. If proliferative changes or atypical cells are reported from fine-needle aspiration cytology, core biopsy or excision of the lesion would be the next step.
The microcalcifications associated with microcysts are rounded, punctuate, and adenosic. If mammograms reveal pleomorphic or dot-dash microcalcifications suggestive of malignancy in an area where benign-appearing microcysts are found with ultrasound, the higher level of suspicion for malignancy associated with the microcalcifications will override the microcystic lesion's benign assessment. The microcalcifications will require a histologic diagnosis, most commonly obtained with stereotactic guidance.
Complex Cystic Masses Intracystic Papillomas and Cyst Wall Proliferation
Ultrasound is ideally suited for its ability to evaluate intracystic structures and cyst walls (Figs. 7.12, 7.13 ). Thus, a thorough examination requires that every cyst be imaged in real-time in at least Diagnostic Criteria 7 Cysts and Intracystic Tumors 105 Comment: Inspissated, hemosiderin-containing, fatty or cellular cyst fluid is more echogenic than water. Because fat is lighter than water and is immiscible with it, a fluid-fluid level is formed. Aspiration yielded a fatty, viscous fluid with no signs of proliferation.
Possible Applications

Smoothly Marginated Carcinomas
The cases in Figures 19.1-19 .3 illustrate that cellular carcinomas, which may be mistaken for benign tumors in imaging studies, show conspicuous abnormalities on color Doppler images. Doppler ultrasound is particularly useful for confirming the suspicious nature of these tumors.
Proliferative Fibroadenomas
The proliferative activity of highly vascularized fibroadenomas can be predicted with Doppler ultrasound (see Fig. 19.7) . Observations of these tumors following cytologic confirmation have confirmed their proliferative tendency. The histologic and cytologic analysis of these tumors consistently show proliferative changes, and therefore surgical excision can be recommended when a hypervascular fibroadenoma is found.
Multifocal and Multicentric Tumors
The detection of multifocality and multicentricity is an important part of preoperative diagnosis. Multifocal lesions can be difficult to identify mammographically, especially in women with dense breasts. If the decision between breast-conserving surgery and mastectomy must be based on ultrasound findings alone, it is very helpful if the diagnosis of multiple tumor masses is confirmed by demonstrating multiple vascularized lesions with color Doppler (Fig. 19.11) .
Scars
In the follow-up of patients who have undergone breast-conserving surgery, major difficulties can arise in the exclusion of recurrent disease. It is advantageous in these cases to exclude a recurrence by noninvasive means (Fig.19.12 ). Postsurgical scars generally have a low blood supply. Even so, much experience is required in differentiating a scar from a recurrence, because many recurrent tumors are hypovascular, especially after prior radiotherapy. If doubt exists concerning recurrence in a mature scar, contrastenhanced breast MRI can be helpful in excluding recurrence. With an area of enhancement in or near the tumor, local recurrence is suspected, and image-guided percutaneous core biopsy should be directed to the area to confirm the diagnosis. Use of an 
Lymph Node Evaluation
The detection of nodal metastases plays an increasingly important role in preoperative planning. In metastatic lymph nodes that do not display some of the typical ultrasound findings, usually focal changes in the cortex of the node, color Doppler can advance the diagnosis by demonstrating a reactive pattern in enlarged lymph nodes. A concomitant increase in blood flow implies a higher index of suspicion for metastasis (Fig. 19.13) . Inflammatory changes can also cause a slight increase in vascularization, but usually this is detectable in the hilar area of the node.
It is very important to detect metastatic involvement of the internal mammary nodes, because that region is not routinely included in lymphadenectomy. Color Doppler has a critical role in the surgical planning of these cases because of the proximity of these nodes to the pleura and internal thoracic vessels. Detecting or excluding direct vascular connections during the planning phase can reduce the subsequent risk of surgical complications (Fig.19.14) .
Prognostic Evaluation
Pathologic studies have shown that a correlation exists between tumor angiogenesis and disease prognosis. This type of study requires a large population to make a prognostic evaluation. The follow-up period in women examined by color Doppler ultrasound is not yet sufficient to make a definitive evaluation. We were able to make a tentative assessment, however, by comparing the numbers of tumor vessels and total blood flow (sum of flow velocities) in 51 patients with nodal metastases and 82 patients without nodal metastases. We found a significant difference with regard to the number of tumor vessels (p < 0.01) in both groups. Measurements of total blood flow showed a tendency toward higher blood flow when metastases were present (p < 0.062). Thus, there is evidence that blood flow measurements can provide at least a crude prognostic assessment in that tumors with less blood flow correlate more frequently with an absence of metastases (Fig.19.15 a, b) .
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Chemotherapy and Follow-Up
Malignant tumors vary greatly in their response to chemotherapy and often develop resistance during the course of treatment. It is very difficult to detect this clinically. We have already tested Doppler ultrasound in experimental animals and in various treatment modalities as a means of evaluating tumor response. Traditionally, tumor size measured clinically or by imaging has been the only parameter used to evaluate response. A constant tumor diameter is interpreted as "no change," and this may justify changing to a different therapy. But as Figure 19 .16 a, b shows, a marked decrease in tumor blood flow may occur without an apparent change in tumor size. Thus, Doppler ultrasound provides a sensitive method for evaluating in vivo the chemotherapeutic response of tumors.
Use of Ultrasound Contrast Agents to Increase Doppler Signal
Ultrasound contrast agents are substances that increase the echogenicity of blood following intravenous injection. By improving the signal-to-noise ratio, these agents enhance the apparent echo contrast between hypervascular and hypovascular areas. Small vessels that were previously invisible can be detected following contrast administration. This technique can help differentiate a hypovascular carcinoma from scar tissue, whose morphology, for example, frequently mimics carcinoma at ultrasound. 
Practical Application
Following intravenous injection of the echo-enhancing agent, it takes approximately 20-40 seconds for blood carrying the contrast material to reach the arterial bed. By increasing the echogenicity of the blood, the agent increases the amplitude of the Doppler signal while causing no significant increase in the frequency shift. Vessels that are faintly visualized in color Doppler become more conspicuous, and previously nonvisualized vessels can be seen. Vessels that were visible before contrast injection and are enhanced by the contrast agent should not be classified as suspicious (Fig. 19.17 a, b) , but a focal increase of blood flow in an area that previously appeared avascular should raise suspicion of carcinoma ( Fig. 19.18 a, b) . In our studies we employed the ultrasound contrast agent Levovist (Schering, Berlin), which is used primarily in cardiology, gastroenterology, and nephrology. The advantages of echo enhancement in breast tumors are currently being tested. The agent consists mainly of galactose granules that are stabilized with a special lipid-based preparation so that they will remain stable for a short time in the bloodstream. The particles are small enough to pass easily through the pulmonary capillary bed. We have observed no side effects other than an occasional warm or cold sensation at the injection site, and the agent may be administered b After the intravenous injection of 8 mL Levovist (400 mg/mL), the tumor still appears avascular but the parenchymal vessel is more clearly demonstrated.
Fig. 19.18 a, b
Local recurrence 2 years after breast-conserving cancer surgery. Ultrasound showed a lesion similar to that in Fig. 19 .17. a The tumor itself is avascular, but a small parenchymal vessel is visible some distance away. b Following contrast injection, the parenchymal vessel appears more prominent. But the major change is the increased signal intensity within the mass, indicating a high blood flow rate in the tumor.
